Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Molecular Biomarker Testing and Targeted Therapy Patterns in Patients with Acute Myelogenous Leukemia (AML) in Community Health Systems in the United States: A Real-World Data Analysis

Francesca Coutinho, Zartash Gul, Anna B. Berry, Michael A. Thompson, Christopher Allen Willner, II, Sowjanya Vuyyala, Haley McCracken, Katherine Geverd, Jeanna Wallenta Law, Frank M. Wolf, Thomas D. Brown, Philip Kuriakose

Blood (2021) 138 (Supplement 1): 4443.

https://doi.org/10.1182/blood-2021-148634

Published: 2021

Journal Articles

Lentiviral Hematopoietic Stem and Progenitor Cell Gene Therapy for Wiskott-Aldrich Syndrome (WAS): Up to 8 Years of Follow up in 17 Subjects Treated Since 2010

Blood (2019) 134 (Supplement_1): 3346.

https://doi.org/10.1182/blood-2019-124665

Published: 2019

Journal Articles

Fludarabine Based Combinations Are Highly Effective as First-Line or Salvage Treatment in Patients with Waldenström Macroglobulinemia

Stefan Peinert, Constantine Tam, H. Miles Prince, Max M. Wolf, E. Henry Januszewicz, David Westerman, John D. Scarlett, John F. Seymour

Blood (2008) 112 (11): 4947.

https://doi.org/10.1182/blood.V112.11.4947.4947

Published: 2008

Journal Articles

High Response Rates with the Combination of Bortezomib, Dexamethasone and the Pan-Histone Deacetylase Inhibitor Romidepsin in Patients with Relapsed or Refractory Multiple Myeloma in a Phase I/II Clinical Trial

Simon James Harrison, MBBS, MRCP, MRCPath, PhD., Hang Quach, MB, BS, FRACP, FRCPA, Kally Yuen, Andrew Strayer, Michael C. Copeman, DPhil, FRACP, S. Peinert, M. Bishton, M. Wolf, H. Januszewicz, MK Kenealy, K. Herbert, David Westerman, D. Carney, J. F Seymour, R. W Johnstone, David Ritchie, MBChB, FRACP, FRCPA, PhD, Miles Prince, MD

Blood (2008) 112 (11): 3698.

https://doi.org/10.1182/blood.V112.11.3698.3698

Published: 2008

Journal Articles

Ancestim (SCF) and High-Dose Twice-Daily Filgrastim (G-CSF) Is Superior to G-CSF Alone or Cyclophosphamide Plus G-CSF for Mobilization of Peripheral Blood Stem Cells (PBSC) in Patients with Indolent Lymphoproliferative Disorders Previously Treated with Fludarabine; Results of a Historically-Controlled Phase-II Study.

John Francis Seymour, MB, BS, PhD, Sue Morgan, MB BS, Miles Prince, MB BS MD, David Alan Westerman, MB BS, Max M. Wolf, MB BS, Dennis A. Carney, MB BS, Kally Yuen, MSc

Blood (2006) 108 (11): 3066.

https://doi.org/10.1182/blood.V108.11.3066.3066

Published: 2006

Journal Articles

Cytotoxic Activity of the Proteasome Inhibitor MLN-273 but Not of Bortezomib Is Inhibited by MDR1.

Holger Rumpold, MD, Anna M. Wolf, MD, Gerold Untergasser, PhD, Guenther Gastl, MD, Eberhard Gunsilius, MD, Dominik Wolf, MD

Blood (2005) 106 (11): 4467.

https://doi.org/10.1182/blood.V106.11.4467.4467

Published: 2005

Journal Articles

Maintenance of Telomere Length in Peripheral Blood CD4 + CD25 + Regulatory T-Cells of Cancer Patients Despite Active Proliferation.

Dominik Wolf, MD, Holger Rumpold, MD, Christian Koppelstaetter, MD, Guenther Gastl, MD, Eberhard Gunsilius, MD, Herbert Tilg, MD, Anna M. Wolf, MD

Blood (2005) 106 (11): 3309.

https://doi.org/10.1182/blood.V106.11.3309.3309

Published: 2005

Journal Articles

Stable RNAi-Mediated Knock-Down of P-Glycoprotein by a Transposon-Based Vector System Restores Imatinib Sensitivity.

Holger F. Rumpold, MD, Anna M. Wolf, MD, Guenther A. Gastl, MD, Eberhard Gunsilius, MD, Dominik G.F. Wolf, MD

Blood (2004) 104 (11): 2090.

https://doi.org/10.1182/blood.V104.11.2090.2090

Published: 2004

Journal Articles

Telomerase Activity and Telomere Length of CD4 + CD25 + Regulatory T-Cells under Conditions of In Vitro and In Vivo Expansion.

Dominik G.F. Wolf, MD, Anna M. Wolf, MD, Christian Koppelstaetter, MD, Holger F. Rumpold, MD, Gert Mayer, MD, Guenther A. Gastl, MD, Eberhard Gunsilius, MD, Herbert Tilg, MD

Blood (2004) 104 (11): 3857.

https://doi.org/10.1182/blood.V104.11.3857.3857

Published: 2004

Journal Articles

The Kinase Inhibitor Imatinib Mesylate Potently Inhibits TNF-α Production by Myeloid Cells and Prevents T-Cell-Mediated Hepatic Injury in Mice.

Anna M. Wolf, MD, Dominik G.F. Wolf, MD, Holger F. Rumpold, MD, Barabara Enrich, TA, Guenther A. Gastl, MD, Gunsilius Eberhard, MD, Herbert Tilg, MD

Blood (2004) 104 (11): 3438.

https://doi.org/10.1182/blood.V104.11.3438.3438

Published: 2004

Journal Articles

Physical and Functional Association of FcαR With Protein Tyrosine Kinase Lyn

Heinz Gulle, Aysen Samstag, Martha M. Eibl, Hermann M. Wolf

Blood (1998) 91 (2): 383–391.

https://doi.org/10.1182/blood.V91.2.383

Published: 1998

Journal Articles

Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia

J Amiral, A Marfaing-Koka, M Wolf, MC Alessi, B Tardy, C Boyer-Neumann, AM Vissac, E Fressinaud, M Poncz, D Meyer

Blood (1996) 88 (2): 410–416.

https://doi.org/10.1182/blood.V88.2.410.bloodjournal882410

Published: 1996

Journal Articles

Antithrombin Milano: a new variant with monomeric and dimeric inactive antithrombin III

M Wolf, C Boyer, A Tripodi, D Meyer, MJ Larrieu, PM Mannucci

Blood (1985) 65 (2): 496–500.

https://doi.org/10.1182/blood.V65.2.496.496

Published: 1985

NARROW

Molecular Biomarker Testing and Targeted Therapy Patterns in Patients with Acute Myelogenous Leukemia (AML) in Community Health Systems in the United States: A Real-World Data Analysis

Lentiviral Hematopoietic Stem and Progenitor Cell Gene Therapy for Wiskott-Aldrich Syndrome (WAS): Up to 8 Years of Follow up in 17 Subjects Treated Since 2010

Fludarabine Based Combinations Are Highly Effective as First-Line or Salvage Treatment in Patients with Waldenström Macroglobulinemia

High Response Rates with the Combination of Bortezomib, Dexamethasone and the Pan-Histone Deacetylase Inhibitor Romidepsin in Patients with Relapsed or Refractory Multiple Myeloma in a Phase I/II Clinical Trial

Cytotoxic Activity of the Proteasome Inhibitor MLN-273 but Not of Bortezomib Is Inhibited by MDR1.

Maintenance of Telomere Length in Peripheral Blood CD4 + CD25 + Regulatory T-Cells of Cancer Patients Despite Active Proliferation.

Stable RNAi-Mediated Knock-Down of P-Glycoprotein by a Transposon-Based Vector System Restores Imatinib Sensitivity.

Telomerase Activity and Telomere Length of CD4 + CD25 + Regulatory T-Cells under Conditions of In Vitro and In Vivo Expansion.

The Kinase Inhibitor Imatinib Mesylate Potently Inhibits TNF-α Production by Myeloid Cells and Prevents T-Cell-Mediated Hepatic Injury in Mice.

Physical and Functional Association of FcαR With Protein Tyrosine Kinase Lyn

Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia

Antithrombin Milano: a new variant with monomeric and dimeric inactive antithrombin III

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only